PUBLIC PROCUREMENT NOTICEExternal opportunity
Preparing English translation…
Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation
Presolicitation published by HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FDA OFFICE OF ACQ GRANT SVCS. Solicitation number: 75F40126Q00382. NAICS: 541714. PSC: AN12. Set-aside: No Set aside used. Place of performan
Opportunity description
Presolicitation published by HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FDA OFFICE OF ACQ GRANT SVCS. Solicitation number: 75F40126Q00382. NAICS: 541714. PSC: AN12. Set-aside: No Set aside used. Place of performance: UNITED STATES. Review the original SAM.gov notice for the complete requirement, amendments and attachments.
Buyer Sign in to view
Response deadline Sign in to view
Delivery Sign in to view
Estimated value Sign in to view
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.